ORIC Pharmaceuticals, Inc. (ORIC) Misses Q2 EPS by 2c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.38), $0.02 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Adeia (ADEA) PT Raised to $50 at BWS Financial
• ORIC Pharmaceuticals (ORIC) PT Raised to $27 at H.C. Wainwright